Medical Atomization Technology + California-Based Manufacturing Breaks Trade Barriers and Reshapes the Industry
Against the backdrop of escalating U.S.-China trade tensions, the vaping industry faces unprecedented tariff pressures. Traditional vaping brands, reliant on Chinese supply chains, have seen costs surge and market competitiveness plummet. However, VPLUS has successfully navigated this challenge through forward-thinking strategies—leveraging 100% U.S.-made, California-produced water-soluble CBD oil combined with medical-grade atomization technology (Dosing™) to offer consumers a safer, fully compliant alternative.
1. How Does VPLUS Overcome Tariff Challenges in the Vaping Industry?
In recent years, the U.S. has imposed steep tariffs (exceeding 25% for some categories) on Chinese vaping products, severely squeezing profit margins for import-dependent brands. Meanwhile, the FDA’s tightening regulations have forced many non-compliant products off the market.
VPLUS’s Solution:
Localized U.S. Production—All CBD water-based formulations are manufactured in VPLUS’s California facility, from extraction to bottling, fully compliant with U.S. cGMP standards, eliminating cross-border tariff risks.
Medical Atomization Replaces Traditional Vaping—The NHNB™ (No Heat, No Burn) system falls outside e-cigarette regulations, avoiding restrictive trade policies entirely.
2. Why Choose Water-Based CBD? Legality, Wellness, and Market Trends
VPLUS’s CBD formula is derived from industrial hemp, compliant with the 2018 U.S. Farm Bill and legally distributable across all 50 states. Compared to traditional vaping, CBD atomization offers: